Diabetes Remote Intervention to improVe Use of Evidence-based Medications

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
Cardiovascular DiseasesDiabetes
Interventions
DRUG

SGLT2 inhibitor, GLP-1 RA

"Immediate initiation of guideline-directed medical therapy. Will also immediately receive the same educational services provided in the Education-First intervention."

BEHAVIORAL

Education-First

For the first 2-months of their participation, patients in this arm will receive curated patient education, an alert to providers, provider education, and then after 2 months, be invited to participate in the remote clinic. The patient education would consist of curated video content and informational worksheets provided by email or secure patient messaging. Provider alerts would happen through notifying of a patient's eligibility for therapy.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Brigham and Women's Hospital

OTHER